Organon Balance Sheet
NYSE: OGNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Organon financial position
At the end of fiscal 2025, Organon reported total assets of $12.87 billion, down 1.8% from a year earlier against total liabilities of $12.12 billion. Shareholders' equity stood at $752.0 million, or 5.8% of assets. The company held $574.0 million in cash and equivalents against $8.64 billion of debt, a net debt position of $8.07 billion.
The current ratio (current assets divided by current liabilities) was 1.82, meaning short-term assets cover obligations due within a year. Debt-to-equity was 11.49.
Summary generated from market data by MetaCap's automated system. Methodology
Organon balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 574.00M | 675.00M | 693.00M | 706.00M | 737.00M | 12.00M | 0 |
| Receivables | 1.33B | 1.36B | 1.74B | 1.48B | 1.38B | 1.04B | — |
| Inventory | 1.41B | 1.32B | 1.31B | 1.00B | 915.00M | 913.00M | — |
| Total Current Assets | 4.35B | 4.35B | 4.51B | 3.93B | 3.76B | 3.57B | — |
| Property, Plant & Equipment | 1.30B | 1.17B | 1.18B | 1.02B | 973.00M | 984.00M | — |
| Goodwill | 4.15B | 4.68B | 4.60B | 4.60B | 4.60B | 4.60B | — |
| Intangible Assets | 1.13B | 1.41B | 533.00M | 649.00M | 651.00M | 503.00M | — |
| Total Assets | 12.87B | 13.10B | 12.06B | 10.96B | 10.68B | 10.11B | — |
| Accounts Payable | 952.00M | 1.15B | 1.31B | 1.13B | 1.38B | 259.00M | — |
| Short-Term Debt | 16.00M | 20.00M | 9.00M | 8.00M | 9.00M | 0 | — |
| Total Current Liabilities | 2.39B | 2.72B | 2.92B | 2.51B | 2.60B | 2.67B | — |
| Long-Term Debt | 8.63B | 8.86B | 8.75B | 8.90B | 9.13B | 0 | — |
| Total Liabilities | 12.12B | 12.63B | 12.13B | 11.85B | 12.19B | 4.62B | — |
| Shareholders' Equity | 752.00M | 472.00M | -70.00M | -892.00M | -1.51B | 5.49B | 7.04B |
| Retained Earnings | 1.11B | 1.01B | 443.00M | -331.00M | -998.00M | 0 | — |
| Total Debt | 8.64B | 8.88B | 8.76B | 8.91B | 9.13B | 0 | — |
| Net Cash (Debt) | -8.07B | -8.21B | -8.07B | -8.21B | -8.40B | 12.00M | 0 |
| Shares Outstanding | 260.32M | 257.80M | 255.63M | 254.37M | 253.55M | — | — |
This table shows 7 annual periods of Organon's balance sheet, from FY 2025 back to FY 2019, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow OGN's reporting calendar. What is a balance sheet?